Thomas Hellmark

Thomas Hellmark is an Associate Professor at the Department of Nephrology, Faculty of Medicine, Lund University. He holds multiple roles including Senior Lecturer, Vice Dean, Head of Office, Principal Investigator, Supervisor, Project Coordinator, and Affiliated Researcher at Infect@LU. His research focuses on autoimmune diseases, particularly anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis (AAV), which causes severe renal failure and lung complications.

• Research Contributions: Deciphering AAV disease biology, studying leukocyte function, complement activation, proteomics, and genetics (GWAS).
• Projects: Formation and Removal of Autoantibodies (assistant supervisor), GOOD-IDES project on bacterial endopeptidase therapy for anti-GBM glomerulonephritis.

His work spans immunology, nephrology, and inflammation, with 93 research outputs and collaborations across Sweden and internationally. He emphasizes patient-derived material in hypothesis-driven and hypothesis-generating research.